A polymorphism in the gene encoding the Fcgamma IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis.

Source:http://linkedlifedata.com/resource/pubmed/id/19005160

Download in:

View as

General Info

PMID
19005160